Cefepime IV Dilution with Normal Saline
Cefepime for IV administration should be reconstituted and then diluted in 50-100 mL of Normal Saline (or other compatible diluent) and infused over 30 minutes for standard dosing.
Standard Reconstitution and Dilution Protocol
Reconstitution
- Cefepime vials must first be reconstituted with an appropriate diluent (Sterile Water for Injection, 0.9% Sodium Chloride, or D5W) according to vial size 1, 2
- The reconstituted solution should then be further diluted for IV infusion 3
Dilution Volume
- Standard dilution: 50-100 mL of Normal Saline for intermittent IV infusion 1, 3
- The diluted solution should be administered over 30-60 minutes as an intermittent infusion 1, 2
Alternative Administration Methods
- Prolonged infusion: Can be administered over 3 hours or as continuous infusion for critically ill patients to optimize pharmacodynamic targets 1
- Extended infusion: May provide better outcomes in patients with resistant pathogens or severe infections by maintaining drug concentrations above the minimum inhibitory concentration for longer periods 1
Dosing Considerations
Standard Adult Dosing
- Typical doses range from 1-2 g IV every 8-12 hours depending on infection severity and renal function 2, 3
- For life-threatening infections: 1000-2000 mg IV every 8-24 hours based on creatinine clearance 3
Pediatric Dosing
- Neonates <36 weeks gestational age: 30 mg/kg/dose IV every 12 hours 4
- Neonates ≥36 weeks: 50 mg/kg/dose IV every 12 hours 4
- Children: 50 mg/kg/dose IV every 8 hours for Pseudomonas infections (maximum 2000 mg/dose) 4
Critical Pharmacokinetic Points
Drug Characteristics
- Elimination half-life: approximately 2-2.3 hours in patients with normal renal function 1, 3, 5
- Protein binding: 20% (relatively low) 1
- Renal excretion: 85% excreted unchanged in urine 1
- Volume of distribution: approximately 0.2 L/kg (18-22 L in adults) 1, 5
Infusion Rate Rationale
- The 30-60 minute infusion time allows for optimal pharmacodynamic target attainment of 70% time above MIC for clinical efficacy 1
- Rapid bolus administration is not recommended as it does not optimize time-dependent killing characteristics of beta-lactam antibiotics 1
Special Population Adjustments
Renal Impairment
- Dosing must be adjusted based on creatinine clearance as cefepime is primarily renally eliminated 3, 5
- Patients on continuous renal replacement therapy (CRRT) may require higher doses (2 g loading dose followed by 1.5-1.75 g every 8 hours) to achieve therapeutic targets 6
Critically Ill Patients
- Consider therapeutic drug monitoring due to high inter-individual variability in volume of distribution and clearance 1
- Extended or continuous infusions may be beneficial for optimizing pharmacodynamic targets 1
Common Pitfalls to Avoid
- Do not administer as rapid IV push: Always dilute and infuse over at least 30 minutes 1, 2
- Monitor for neurotoxicity: Particularly in patients with impaired renal function, as reports of neurotoxicity have increased with higher cefepime exposures 1
- Avoid mixing with alkaline solutions: Do not mix cefepime with sodium bicarbonate or other alkaline solutions in the IV line 7
- Ensure adequate renal dose adjustment: Failure to adjust for renal function can lead to drug accumulation and increased neurotoxicity risk 1, 3